T. Rowe Price Associates’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,095,263
| Closed | -$50.1M | – | 2596 |
|
|
2017
Q4 | $50.1M | Sell |
1,095,263
-35,542
| -3% | -$1.62M | 0.01% | 861 |
|
|
2017
Q3 | $50.7M | Buy |
1,130,805
+370,583
| +49% | +$16.6M | 0.01% | 843 |
|
|
2017
Q2 | $22.7M | Sell |
760,222
-8,490
| -1% | -$254K | ﹤0.01% | 1125 |
|
|
2017
Q1 | $17.1M | Sell |
768,712
-42,006
| -5% | -$932K | ﹤0.01% | 1221 |
|
|
2016
Q4 | $15.3M | Buy |
810,718
+787,020
| +3,321% | +$14.8M | ﹤0.01% | 1218 |
|
|
2016
Q3 | $711K | Buy |
23,698
+98
| +0.4% | +$2.94K | ﹤0.01% | 1880 |
|
|
2016
Q2 | $907K | Sell |
23,600
-166,829
| -88% | -$6.41M | ﹤0.01% | 1741 |
|
|
2016
Q1 | $7.25M | Buy |
190,429
+123,500
| +185% | +$4.7M | ﹤0.01% | 1332 |
|
|
2015
Q4 | $2.94M | Sell |
66,929
-30,877
| -32% | -$1.36M | ﹤0.01% | 1485 |
|
|
2015
Q3 | $3.98M | Sell |
97,806
-294
| -0.3% | -$12K | ﹤0.01% | 1469 |
|
|
2015
Q2 | $5.23M | Buy |
+98,100
| New | +$5.23M | ﹤0.01% | 1471 |
|